SARS-CoV-2 RdRp (IP2/IP4) gene stabilized RNA as positive control: shipping at Room Temperature


EVAg

Produced by
: AMU
Shipping From
: Marseille - FR

Product Description

Ref-SKU:
001K-03934
Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the RdRp (IP2/IP4) gene, for 100 Rxns (Target designed by Institut Pasteur: https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detection-of-sars-cov-2-institut-pasteur-paris.pdf?sfvrsn=3662fcb6_2) The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)
Product Risk Group: 

Information on the related virus

Virus name: 


Unit definition: 
1 vial

In stock

200,00 €
(Cost per access for Academics)

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

Can it be used to produce GMO: 
No
Shipping conditions: 
Room Temperature
IATA Classification: 
NON DANGEROUS GOODS
Storage conditions: 
Freeze Dried (-20C)
Targeted region: 
RdRp (IP2/IP4) gene of the SARS-CoV-2
Technical recommendation: 
Extraction is mandatory before use in real time RT-PCR
Specificity documented: 
Yes
Specificity: 
SOP
Previous Name or Taxonomy: